Looks like they are getting ready for some positive news flow to give the cap raise participants a quick exit.
what a shame and missed opportunity to strengthen the register by offering favourable terms to long standing investors who have supported the company over the years.
I won’t be participating and I intend to join the traders on the next pump.
until they generate a cashflow, this isn’t one to hold imo.
- Forums
- ASX - By Stock
- NUH
- Ann: Nuheara Clinical Trial and FDA 510(K) Pathway Update
Ann: Nuheara Clinical Trial and FDA 510(K) Pathway Update, page-11
-
- There are more pages in this discussion • 19 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NUH (ASX) to my watchlist
(20min delay)
|
|||||
Last
8.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $21.91M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
NUH (ASX) Chart |
Day chart unavailable
The Watchlist
SER
STRATEGIC ENERGY RESOURCES LIMITED
David DeTata, Managing Director
David DeTata
Managing Director
SPONSORED BY The Market Online